-
PHRT study of longitudinal sampling in ovarian cancer
Study
EGAS50000001424
-
Single cell RNA sequencing reveals induced bifurcated differentiation after RUNX1::RUNX1T1 depletion in patient-derived leukemic blasts
Study
EGAS00001008050
-
The INFORM Precision Medicine Study for High-Risk Pediatric Malignancies
Study
EGAS00001005112
-
Phenotypic characterization and prognostic impact of CD103+ tissue-resident memory T cells in diffuse large B cell lymphoma
Study
EGAS50000000943
-
Assessing gene expression profiling from FFPE Patient Samples: A Comparison of Two Library Preparation Approaches and Recommendations
Study
EGAS50000001066
-
A renal cell carcinoma tumorgraft platform to advance precision medicine
Study
EGAS00001005516
-
Clinical Utility of Breast cancer Research by Inocras, Catholic university hospital and Samsung medical center
Study
EGAS50000001377
-
Comprehensive benchmarking of methods for mutation calling in circulating tumor DNA
Study
EGAS50000001313
-
Rare germline variants in patients with personal and family history of colorectal cancer
Study
EGAS50000000606
-
Identification of novel colorectal cancer predisposition genes
Study
EGAS00001005118
-
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancer
Study
JGAS000875
-
High MAPK Activity Leading to Reduced WNT Signaling Drives Metastasis in Colorectal Cancer
Study
EGAS50000001231
-
EXPRESSION OF ANTIBODY-DRUG CONJUGATE TARGETS IN BREAST CANCER METASTASES AND NORMAL TISSUE
Study
EGAS50000001334
-
Genomic and transcriptomic analysis of thymic epithelial tumors
Study
EGAS00001004227
-
Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer
Study
EGAS50000001554
-
Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer - DEDICATION co-hort
Dataset
EGAD50000002230
-
Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer - Biobank co-hort
Dataset
EGAD50000002231
-
Liquid biopsy-based minimal residual disease monitoring for early risk stratification and decision-making in advanced non-small cell lung cancer
Dac
EGAC50000000832
-
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer
Study
EGAS50000001021
-
A single-cell multi-omic atlas of nodal B-cell non-Hodgkin lymphomas
Study
EGAS50000000342
-
Whole-exome sequencing identifies new pathogenic germline variants in patients with colorectal polyposis
Study
EGAS50000000591
-
Development of New Diagnostics, Therapeutics, and Prevention Methods for Personalized Medicine Based on Comprehensive Cancer-Related Gene Exome Analysis and Information Analysis Using Cancer Specimens Stored in TMDU Biobank.
Study
JGAS000863
-
IMMUcan SCCHN1 cohort
Study
EGAS50000001533
-
DAC for lymphoma IFZ Essen
Dac
EGAC50000000521
-
IMMUcan Lung NSCLC2 cohort
Study
EGAS50000001558